newsfilter
← Latest News
Business Wire·

MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced